The Truth Is In…
July 2nd, 2007
Who ever said, "vino veritas" (in wine, there is truth), hasn’t written enough. I say, "in writing veritas." MarketWatch asked me to write an article about one’s investment strategy in the interest rate environment on the horizon. When I first sat down to write, I thought that I was a bit neutral on the direction of interest rates. However, by the time I finished (as you’ll see), it was painfully obvious that interest rates are more likely to go down than up. It’s a story of global prosperity that has been in part prepped up by finite sources (mostly debt).
I would not bet my career or even a bottle of fine beer (Fat Tire - those in Colorado will know), but there are too many "uncertainties" on the horizon for higher interest rates. In the article, I offered two stocks, Glaxosmithkline (GSK) and Johnson & Johnson (JNJ) that should do well in any interest rate environment.
Add to del.icio.us | Digg this storyEntry Filed under: Analysis & Research
RSS 
Send Email
3 Comments Add your own
1. David | July 3rd, 2007 at 12:53 am
Nice article and exposure at Marketwatch.
David
2. TIm | July 3rd, 2007 at 1:24 pm
Nice article. I like your writing style … it’s succint with a touch of humor. Your honesty (i.e., who knows where interest rates are going to go …) is refreshing. I look forward to reading your book in September. TIM
3. Vitaliy | July 3rd, 2007 at 3:33 pm
Thank you very much!!!
Leave a Comment
Some HTML allowed:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>
Trackback this post | Subscribe to the comments via RSS Feed